Journal of Neuroscience study examines medicinal properties of cannabis
OHSU research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction.
The study, conducted in a rodent model, provides additional rationale for the development of therapeutics using cannabinoid receptors to treat chronic pain, which afflicts about 30 percent of the U.S. population. OHSU investigators studied the function of two forms of cell membrane receptors that bind cannabinoids that occur naturally within the body, called endocannabinoids.
“It may be an avenue where we can get better pain medications that are not addictive,” said senior author Susan Ingram, Ph.D., an associate professor of neurosurgery in the OHSU School of Medicine.
Ingram and colleagues report the treatment of chronic pain has challenged the medical system, with medications that are ineffective or create serious side effects: “However, emerging data indicate that drugs that target the endocannabinoid system might produce analgesia with fewer side effects compared with opioids.”
The body’s endocannabinoid system comprises receptors, endocannabinoid molecules and enzymes that make and degrade the endocannabinoids located in the brain and throughout the central and peripheral nervous system. The research team focused on two cannabinoid receptors, known as CB1 and CB2, in the rostral ventromedial medulla – a group of neurons located in the brainstem known to modulate pain. The study is the first to examine CB1 and CB2 receptor function at the membrane level in late adolescent and adult neurons.
The researchers observed that chronic inflammatory pain increased activity of CB2 receptors and decreased CB1 activity. Cannabis activates both CB1 and CB2 receptors equally. The study suggests that selective activation of CB2 receptors contributes to the medicinal benefit of cannabis while minimizing the propensity of the other cannabinoid receptor, CB1, to induce tolerance and withdrawal. Ingram said the next phase of the research will further explore this area of brain circuitry, which ultimately could lead to the development of a new class of pain medications.
Receive an email update when we add a new PAIN article.
The Latest on: Non-addictive pain relief
via Google News
The Latest on: Non-addictive pain relief
- Adynxx Reports Third Quarter 2019 Financial Resultson November 14, 2019 at 4:40 pm
SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class ...
- Budding solutions: Athletes advocate for CBD use, but the risks and regulations remain hazyon November 12, 2019 at 6:07 am
Advocates have cited perceived benefits like relief from pain, inflammation and stress, and increased focus, better recovery and sleep — not to mention the non-addictive characteristics of CBD that ...
- Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buyon November 6, 2019 at 11:07 am
Vertex is developing non-opioid painkillers, and considering the current opioid crisis, the move into the pain management market is likely to be huge ... That belief was based on the drug companies ...
- PsychoGenics Awarded NIH HEAL Initiative Contract for Preclinical Screening Platform for Pain (PSPP)on November 6, 2019 at 5:52 am
“There is a tremendous need for non-addictive treatments for the more than 50 million individuals ... About the HEAL Initiative The HEAL Initiative is a trans-NIH research effort focused on improving ...
- Aqua Nutrition is now offered Nationwide Through Mr. Checkout's Direct Store Delivery Distributors.on November 2, 2019 at 1:20 am
Our product line offers 4 different sprays to be used for the following: Pain Relief, Energy Boost, Restful Sleep ... reliable and legal producer of CBD products. CBD is a natural, non-toxic, ...
- An invisible supply: Opiates afflict Washington County, tooon October 26, 2019 at 1:00 pm
They pushed claims that opioids improved quality of life and cognitive functioning, and they promoted false statements about the non-addictive nature of the drugs, suggesting that alternative pain ...
- Murray firm studying what could be next generation of non-addictive pain medson October 20, 2019 at 5:00 pm
Utah researchers are now testing what could become a new generation of non-opioid and non-addictive pain medications. "We can give them good pain relief, but at the same time, we’re looking out for ...
- Wireless pain management device may be opioid alternativeon October 1, 2019 at 10:18 am
“The ability to manufacture extremely small bioelectronic devices creates tremendous opportunities for new bioelectronic medicines like non-addictive pain relief,” Robinson said. According to the ...
- NeuroCycle Therapeutics Awarded NIH HEAL Initiative Grant to Research a Novel Non-Addictive, Non-Opioid Treatment of Chronic Painon October 1, 2019 at 6:15 am
to advance development of its novel non-addictive treatment of chronic musculoskeletal pain. Chronic musculoskeletal pain, which includes pain caused by osteo- and rheumatic arthritis, is one of the ...
via Bing News